23andMe, once a favorite in Silicon Valley, bought by Regeneron Pharmaceuticals
Regeneron Pharmaceuticals to Acquire 23AndMe for $256 Million Regeneron Pharmaceuticals has announced its intent to purchase the bankrupt genetic testing company 23AndMe for $256 million. This move presents a chance for Regeneron to obtain a wealth of genetic samples and data, including details from over 15 million customers. However, this acquisition has sparked concerns among […]
Regeneron Pharmaceuticals is set to purchase 23andMe and its genetic information for $256 million.
Regeneron Pharmaceuticals to Acquire 23andMe from Bankruptcy Regeneron Pharmaceuticals announced on Monday its intention to purchase 23andMe for $256 million as the company emerges from bankruptcy. This acquisition includes 23andMe’s personal genomic service, Total Health and Research Services, along with a substantial biobank that holds genetic data from over 15 million customers. All genetic testing […]
Regeneron plans to acquire nearly all of 23andMe’s assets for $256 million.
Regeneron Acquires 23andMe Assets Amid Bankruptcy Regeneron Pharmaceuticals has declared its intention to acquire nearly all of the assets belonging to 23andMe, a genetic testing firm, following a court-supervised auction. The company has agreed to pay $256 million for these assets, with the auction occurring as part of 23andMe’s Chapter 11 bankruptcy protection filing from […]